Cognition market Target medical and academic institutions pursuing cognitive disorders such as Alzheimer’s and ADHD, positioning COGNISION as a noninvasive diagnostic and monitoring tool to expand adoption in hospitals, clinics, and research centers.

Clinical deployment Leverage existing use in academic, clinical, and pharmaceutical studies to upsell to additional departments and specialties within healthcare networks, driving cross-site expansion and long-term contracts.

Military validation Highlight validated real-world use by military personnel to assess cognitive effects of injuries as a differentiator when engaging defense contractors, veterans health programs, and crisis response clinics.

Revenue growth Position COGNISION as a scalable platform with potential ARR growth through expanded clinical trials, regulatory submissions, and multi-site implementations to increase average deal size and customer lifetime value.

Competitive edge Emphasize noninvasive, cognitive-focused analytics in contrast to invasive or less accessible technologies, targeting brain health startups and mid-market neurotech players for partnerships, co-development, or OEM opportunities.